None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: preterm neonates of gestational age 30-36+6/7 weeks diagnosed with respiratory distress syndrome
Exclusion criteria
Exclusion criteria: neonates who had undergone endotracheal intubation or had received surfactant prior to randomization , neonates with gross congenital anomalies whose caretakers refuse to give consent to participate in study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment failure Defined as requirement of an use of an alternative NRS modality NIPPV or BiPAP, Requirement of IMV within 72 hours of postnatal age Timepoint: Treatment failure Defined as requirement of an use of an alternative NRS modality NIPPV or BiPAP, Requirement of IMV within 72 hours of postnatal age | — |
Secondary
| Measure | Time frame |
|---|---|
| Requirement of surfactant replacement therapy, Pneumothorax, Mortality or BPD (defined as oxygen requirement at 28 days of postnatal age), Mortality, BPD (defined as oxygen requirement at 28 days of postnatal age), Duration of NRS support, Duration of IMV support, Duration of both NRS and IMV support, Duration of hospital stay, Severe intraventricular hemorrhage, Necrotizing enterocolitis stage 2 or more as per modified Bell’s staging, Retinopathy of prematurity (ROP) requiring intervention, Nasal injuryTimepoint: respiratory support started within 6hours | — |
Countries
India
Contacts
Ankura hospital for women and children